trial
-
Recon
CollPlant Announces Completion of Patient Recruitment for Clinical Trial of Vergenix™FG (Flowable Gel) for the Treatment of Chronic Wounds
CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, announce that…
Read More » -
Sports Medicine
Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat…
Read More » -
Spine
Operative treatment of adult spinal deformity improves health-related quality of life
MINNEAPOLIS — When compared with conservative treatments, operative treatments of adult spinal deformities result in better health-related quality of life…
Read More » -
Extremities
No measurable clinical benefit likely in aspiration for ankle fractures
By Monica Jaramillo Results of this randomized, double-blinded placebo controlled trial indicated aspiration of acute ankle fractures did lead to…
Read More » -
Extremities
Lower pain scores seen with continuous peripheral nerve block vs single injection block
By Monica Jaramillo Results of this prospective randomized controlled trial showed patients who underwent surgery for an ankle fracture and…
Read More » -
Recon
HTO combined with abrasion and microfracture seen as effective for medial OA, varus malalignment
By Monica Jaramillo High tibial osteotomy along with chondral resurfacing is efficacious for patients with severe medial osteoarthritis and varus…
Read More » -
Spine
Bone Therapeutics Treats First Patients in Pioneering Trial for Minimally Invasive Treatment of Failed Spinal Fusion
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the fifth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Hospitals
FLEXION THERAPEUTICS GRANTED FAST TRACK STATUS BY THE FDA FOR FX006 FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE
BURLINGTON, MASS., September 01, 2015 – Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced that the U.S. Food and Drug Administration (FDA)…
Read More » -
Spine
InVivo Therapeutics Featured in Front Page Article in The Boston Globe
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) has announced that the company and the company’s ongoing trial of its investigational Neuro-Spinal…
Read More » -
Financial
InVivo’s Q2 net loss hits $10.4M as spinal cord injury trial shows early success: 5 things to know
By Laura Dyrda InVivo Therapeutics reported $10.4 million net loss in the second quarter of 2015. However, CEO Mark Perrin is focused…
Read More » -
Spine
Dr. Carl Lauryssen to head Spinal Kinetics M6-C artificial disc trial at Lakeview Regional Medical Center — 5 things to know
By Laura Dyrda Carl Lauryssen, MD, a spine surgeon with NeuroTexas, will be co-principal investigator of the study for the…
Read More » -
Extremities
Cartiva Announces Positive Final Data from its Cartiva SCI Pivotal Trial for Great Toe Arthritis
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions,…
Read More » -
Recon
Bone Therapeutics Reports First Results of Its Phase IIA Trial for PREOB® in Severe Osteoporosis
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE) the bone cell therapy company addressing high unmet medical needs in the field of…
Read More »